Alimak Group (ALIG) investor relations material

Executive summary

• Q3 order intake rose 16% to MSEK 1,789, including 4% organic growth; revenue rose 8% to MSEK 1,783, while organic revenue declined 2%.

• Adjusted EBITA increased 11% to MSEK 318; margin rose to 17.8% from 17.3%, with Pro-Bel contributing 106 bps to quarterly margin.

• Nine-month revenue was broadly flat at MSEK 5,198; adjusted EBITA fell to MSEK 896 from MSEK 909, and net profit to MSEK 464 from MSEK 501.

Financial highlights

• Q3 net profit rose 13% to MSEK 150; excluding items affecting comparability, earnings were MSEK 167 versus MSEK 173. EPS was SEK 1.42; adjusted EPS was SEK 1.88 versus SEK 1.78.

• Reported EBITA was MSEK 300 versus MSEK 246, including MSEK -18 of items affecting comparability, mainly cost-reduction and efficiency activities.

• Gross profit rose 19% to MSEK 756; gross margin was 42.4% versus 38.3%, and 42.7% versus 40.2% excluding items affecting comparability.

• Operating cash flow was MSEK 196, unchanged YoY; working capital increased MSEK 57, mainly due to Pro-Bel and September revenue phasing.

• Nine-month EBIT was MSEK 758 versus MSEK 790; basic EPS was SEK 4.38 versus SEK 4.73, and operating cash flow was MSEK 551 versus MSEK 554.

Outlook and guidance

• Financial targets remain 8%-12% average annual revenue growth, 20% adjusted EBITA margin by 2028, and leverage below 2.5x over time.

• Cost-reduction and efficiency actions target MSEK 80 in annual savings, with full impact from Q2 2027; one-off implementation costs are expected to total MSEK 40.

• Leverage is expected to fall below 2.5x by year-end, including 12 months of Pro-Bel earnings, supported by cash generation.

• Quarterly amortization is expected to be slightly above MSEK 50; finance net around MSEK 40 per quarter and tax rate around 28% at the current country mix.